Clinical review report [electronic resource] : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) with an inadequate response, loss of response, or intolerance to either conventional UC therapy or a tumour necrosis factor

Published: [S.l.] : Canadian Agency for Drugs and Technologies in Health, 2019.
Edition: Final (with redactions)

Finding items...

Restrictions on Access

License restrictions may limit access.

Genre(s)

Note

Title from content provider.

View MARC record | catkey: 44546489

Actions for Clinical review report [electronic resource] : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) with an inadequate response, loss of response, or intolerance to either conventional UC therapy or a tumour necrosis factor